For Fragments Based Innovations
 
 
 
 
Products
Rare Organics
Structure Product Information
ISO074
Isoquinoline, 3,4-dihydro-6,7-dimethoxy-
[3382-18-1]
Hydrochloride [20232-39-7]
ISO075
1H-Isoindole-1,3(2H)-dione, 2-[[(5R)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-
ISO076
1H-Isoindole-1,3(2H)-dione, 2-[(2S)-2-oxiranylmethyl]-
[61596-47-0]
ISO077
1H-Isoindole-1,3(2H)-dione, 2-[(2S)-2-hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-
[1369969-44-7]
ISO078
Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-,(1R)- ethanedioate (1:1)
[50896-90-7]
ISO079
Isoquinolinium, 2,2'-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1'S,2R,2'S)-rel-, dibenzenesulfonate
[96946-50-8]
ISO080
2H-Isoindole-2-carboxylic acid, 1,3-dihydro-1,3-dioxo-, ethyl ester
[22509-74-6]
ISO081
1H-Isoindol-1-one, 4-amino-2,3-dihydro-
[366452-98-4]
LEU001
Leucine, N-benzoyl-
[17966-67-5]
LEU002
L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester
[96829-58-2]
MAL002
Malonic acid, 2-[(4-acetylamino-3- ethoxy ˇ§Cphenylamino)-methylene]-,diethyl ester
MET002
Methanediol, 1-(3-furanyl)-, 1,1-diacetate
[859077-01-3]
MET003
Methanone, (4-chlorophenyl)phenyl-
134-85-0
MET004
Methanimidamide, N'-(1,4-dihydro-6-methyl-5-nitro-4-oxo-2-pyrimidinyl)-N,N-dimethyl-
[151587-54-1]
MET005
Methanimidamide, N,N-dimethyl-N'-1H-pyrrolo[3,2-b]pyridin-5-yl-
[207849-65-8]
MET006
Methanimidamide, N'-[1,6-dihydro-4-methyl-5-nitro-6-oxo-1-[(phenylmethoxy)methyl]-2-pyrimidinyl]-N,N-dimethyl-
[518316-52-4]
MET014
Methanone, bis(3-methyl-2-thienyl)-
[30717-55-6]
MET016
Methanone, cyclohex-3-enyl(1-methyl-1H-indol-3-yl)-
MET018
4-methoxybenzoic acid, 11-thiol-undecyl-
MET019
Methanimidamide, N',N'''-(4-cyano-1H-pyrazole-3,5-diyl)bis[N,N-dimethyl-
[640284-71-5]
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. 
Page [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119]

 


New products

Copyright © 2010-2015 Fragmenta. All rights reserved.  Terms of Use | Order and Payment Terms | Help